Last update 30 Nov 2024

CD19 CAR T-Cell Therapy(Vinmec Research Institute of Stem Cell and Gene Technology)

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication
Acute Lymphoblastic LeukemiaB-Cell LymphomaCD19 positive Non-Hodgkin Lymphoma
Inactive Indication-
Originator Organization
Vinmec Research Institute of Stem Cell and Gene Technology
Active Organization
Vinmec Research Institute of Stem Cell and Gene Technology
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CD19 CAR T-Cell Therapy(Vinmec Research Institute of Stem Cell and Gene Technology)
NCT06027957 / RecruitingPhase 1IIT
Phase I Clinical Trial Evaluating the Safety and Efficacy of Point-of-care CAR-T-cell Therapy in the Treatment of Relapsed/Refractory CD19+ Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
100 Clinical Results associated with CD19 CAR T-Cell Therapy(Vinmec Research Institute of Stem Cell and Gene Technology)
Login to view more data
100 Translational Medicine associated with CD19 CAR T-Cell Therapy(Vinmec Research Institute of Stem Cell and Gene Technology)
Login to view more data
100 Patents (Medical) associated with CD19 CAR T-Cell Therapy(Vinmec Research Institute of Stem Cell and Gene Technology)
Login to view more data
100 Deals associated with CD19 CAR T-Cell Therapy(Vinmec Research Institute of Stem Cell and Gene Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Lymphoblastic LeukemiaPhase 1
VN
Vinmec Research Institute of Stem Cell and Gene Technology
02 Aug 2023
B-Cell LymphomaPhase 1
VN
Vinmec Research Institute of Stem Cell and Gene Technology
02 Aug 2023
CD19 positive Non-Hodgkin LymphomaPhase 1
VN
Vinmec Research Institute of Stem Cell and Gene Technology
02 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free